David L. Lucchino - 05 Jul 2023 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)

Role
President and CEO, Director
Signature
/s/ James P. Abely, Attorney-in-Fact for David L. Lucchino
Issuer symbol
KRRO
Transactions as of
05 Jul 2023
Net transactions value
-$943
Form type
4
Filing time
07 Jul 2023, 16:56:15 UTC
Previous filing
12 Jul 2023
Next filing
12 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FREQ Common Stock Options Exercise +9,091 +2.1% 432,512 05 Jul 2023 Direct F1
transaction FREQ Common Stock Sale $943 -2,773 -0.64% $0.3400 429,739 06 Jul 2023 Direct F2, F3
transaction FREQ Common Stock Options Exercise +9,091 +2.1% 438,830 06 Jul 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Restricted Stock Unit Options Exercise -9,091 -3% 290,909 05 Jul 2023 Common Stock 9,091 Direct F1, F4
transaction FREQ Restricted Stock Unit Options Exercise -9,091 -3.1% 281,818 06 Jul 2023 Common Stock 9,091 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive on share of Issuer common stock.
F2 Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
F3 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.33 to $0.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F4 The restricted stock units will fully vest on July 4, 2023.